These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
62 related items for PubMed ID: 1641820
1. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial. Bounameaux H, Banga JD, Bluhmki E, Coccheri S, Fiessinger JN, Haarmann W, Lockner D, Mahler F, Ninet J, Schneider PA. Thromb Haemost; 1992 Mar 02; 67(3):306-9. PubMed ID: 1641820 [Abstract] [Full Text] [Related]
2. An exploratory trial of two dosages of a novel synthetic thrombin inhibitor (napsagatran, Ro 46-6240) compared with unfractionated heparin for treatment of proximal deep-vein thrombosis -- results of the European multicenter ADVENT trial. Bounameaux H, Ehringer H, Hulting J, Rasche H, Rapold HJ, Zultak M. Thromb Haemost; 1997 Sep 02; 78(3):997-1002. PubMed ID: 9308743 [Abstract] [Full Text] [Related]
3. Intermittent regional therapy with rt-PA is not superior to systemic thrombolysis in deep vein thrombosis (DVT)--a German multicenter trial. Schwieder G, Grimm W, Siemens HJ, Flor B, Hilden A, Gmelin E, Friedrich HJ, Wagner T. Thromb Haemost; 1995 Nov 02; 74(5):1240-3. PubMed ID: 8607102 [Abstract] [Full Text] [Related]
4. Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis. Marder VJ, Brenner B, Totterman S, Francis CW, Rubin R, Rao AK, Kessler CM, Kwaan HC, Sharma GV, Fong KL. J Lab Clin Med; 1992 May 02; 119(5):485-95. PubMed ID: 1583404 [Abstract] [Full Text] [Related]
7. Fibrinolytic therapy of deep vein thrombosis with continuous intravenous infusion of a recombinant tissue plasminogen activator. Zimmerman R, Gürsoy A, Horn A, Harenberg J, Diehm C, Kübler W. Semin Thromb Hemost; 1991 Jan 02; 17(1):48-54. PubMed ID: 1904629 [Abstract] [Full Text] [Related]
20. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator]. Verstraete M, Bory M, Collen D, Erbel R, Lennane RJ, Mathey D, Michels HR, Schartl M, Uebis R, Bernard R. Klin Wochenschr; 1988 Jan 02; 66 Suppl 12():77-85. PubMed ID: 3126348 [Abstract] [Full Text] [Related] Page: [Next] [New Search]